- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.02. | When licensing deals go bad - Novo sues KBP Bio for $830m | ||
| 19.02. | RFK 'willing to be wrong' on vaccines, but a probe is coming | ||
| 18.02. | Shionogi gets approval in Japan for ADHD digital therapeutic | ||
| 18.02. | Can Dupixent plug treatment gap in bullous pemphigoid? | ||
| 18.02. | Four more drugs in keenly watched ALS trial miss the mark | ||
| 18.02. | First biosimilar fast-acting insulin reaches US market | ||
| 18.02. | Bill would allow AIs to prescribe FDA-approved drugs | ||
| 17.02. | Bavarian Nordic chikungunya vaccine gets FDA okay | ||
| 17.02. | Istesso backer sees silver lining in failed arthritis trial | ||
| 17.02. | GSK gets ready for its next big vaccine launch | ||
| 17.02. | Ono poised to join Daiichi in TGCT market after FDA nod | ||
| 17.02. | US federal job cuts reach the FDA, CDC, say reports | ||
| 14.02. | First self-amplifying mRNA vaccine reaches Europe | ||
| 14.02. | EU approves CSL's once-monthly HAE drug Andembry | ||
| 14.02. | BMS study of Opdualag in adjuvant melanoma ends in failure | ||
| 14.02. | Apple study will look at the role tech can play in health | ||
| 14.02. | RFK Jr-led commission will assess 'threats' to children | ||
| 13.02. | Kennedy confirmed as HHS Secretary | ||
| 13.02. | Santhera's DMD drug poised for wider rollout in Germany | ||
| 13.02. | Sanofi, J&J abandon trial of E coli vaccine after poor data | ||
| 13.02. | FDA changes its mind on Astellas' geographic atrophy drug | ||
| 13.02. | Small study finds GLP-1 drug can curb excess alcohol use | ||
| 13.02. | Ex-DeepMind scientist launches drug discovery company | ||
| 12.02. | Abcuro raises $200m to take muscle disease drug to market | ||
| 12.02. | With Merck circling, SpringWorks gets new drug approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
